ARTICLES BY THIS AUTHOR
- 2/6/2020
NCPA sets 2020 Pharmacy Ownership Workshop dates
The Pharmacy Ownership Workshop, sponsored by McKesson, will cover financing, marketing, business development, and profitable merchandising ideas. - 2/6/2020
FIP releases coronavirus guidelines for pharmacists
The International Pharmaceutical Federation guidelines will be downloadable in the six official United Nations languages along with other resources on the FIP website. - 2/6/2020
Dr. Reddy’s debuts generic Syprine
Dr. Reddy's generic Syprine offers an alternative that can be stored at room temperature throughout its 24-month shelf life. - 2/5/2020
Cardinal Health posts 5% revenue growth in Q2
Cardinal Health's second-quarter revenue for the pharmaceutical segment was $35.7 billion, a hike of 6% from the same period last year. - 2/5/2020
FDA clears 1st treatment for peanut allergy in children
The FDA has approved Palforzia, the first treatment for peanut allergy in children. - 2/5/2020
Coronavirus fears drive shortages of respiratory masks, sanitizers
The spread of the coronavirus is leading to a shortage of masks and sanitizers in retailers nationwide. - 2/5/2020
BioMotiv, Bristol-Myers Squibb launch Anteros Pharmaceuticals
Anteros Pharmaceuticals will focus on inflammatory diseases. - 2/4/2020
Fresenius Kabi introduces Glucagon Emergency Kit
Fresenius Kabi's glucagon emergency kit provides a treatment for severe hypoglycemia in pediatric and adult patients with diabetes. - 2/4/2020
Hy-Vee offers free biometric screenings
Hy-Vee dietitians working out of Hy-Vee Healthy You Mobiles will offer free biometric screenings to customers at 91 Hy-Vee stores - 2/4/2020
Lupin gets FDA blessing for generic Arava
Leflunomide tablets had a market value of roughly $44 million, according to December 2019 IQVIA data.